Skip to Main Content

Paper Details

Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1.
Cardiovasc Res
46
2021
DD, IL-6, LDL-C, ORION, ORION-1, PCSK9, PCSK9 siRNA, Patients, RNA, Small-interfering RNA, TNF, TNF-, cardiovascular disease, cholesterol, humans, immune cells, inclisiran, interleukin 6, kexin type 9, leucocytes, low-density lipoprotein cholesterol, lymphocytes, monocytes, neutrophils, patients, platelet, platelets, proprotein convertase, proprotein convertase subtilisin/kexin type 9, siRNA, small-interfering RNA, subtilisin, thrombocytopenia, tumour necrosis factor
Author NameAffiliation
R. Scott WrightMayo Clinic
John J P KasteleinAcademic Medical Center, University of Amsterdam
  • 1 - 2

Datasets

Release 1.2